azacrin has been researched along with toxoflavin in 1 studies
Studies (azacrin) | Trials (azacrin) | Recent Studies (post-2010) (azacrin) | Studies (toxoflavin) | Trials (toxoflavin) | Recent Studies (post-2010) (toxoflavin) |
---|---|---|---|---|---|
6 | 0 | 0 | 82 | 0 | 53 |
Protein | Taxonomy | azacrin (IC50) | toxoflavin (IC50) |
---|---|---|---|
90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 1.0566 | |
Cathepsin B | Homo sapiens (human) | 0.0461 | |
procathepsin L isoform 1 preproprotein | Homo sapiens (human) | 0.2258 | |
cathepsin S isoform 1 preproprotein | Homo sapiens (human) | 0.1765 | |
dual specificity protein phosphatase 3 | Homo sapiens (human) | 1.36 | |
heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 1.0566 | |
tyrosine-protein phosphatase non-receptor type 22 isoform 1 | Homo sapiens (human) | 1.295 | |
dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | 2.32 | |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 1.24 | |
Lysine-specific demethylase 4A | Homo sapiens (human) | 2.5 | |
Transcription factor 4 | Homo sapiens (human) | 0.8 | |
Catenin beta-1 | Homo sapiens (human) | 5.4 | |
NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 0.87 | |
Lysine-specific demethylase 4C | Homo sapiens (human) | 0.5205 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
1 other study(ies) available for azacrin and toxoflavin
Article | Year |
---|---|
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |